Literature DB >> 2611404

Metachronous seeding of lymph node metastases in rats bearing the MT-100-TC mammary carcinoma: the effect of elective lymph node dissection.

P M Ward1, L Weiss.   

Abstract

Following the introduction of cancer cells into the lymphatic system, metastases in 'down-stream' lymph nodes often appear in a sequential manner. This could be due to synchronous seeding of the in-line nodes with progressively diminishing numbers of tumorigenic cancer cells, or alternatively, by discrete, stepwise (metachronous) seeding of 'down-stream' nodes by 'up-stream' nodal metastases acting as 'generalizing' sites. Metachronous seeding to local lymph nodes is potentially curable by elective lymph node dissection; synchronous seeding is not. Synchronous versus metachronous seeding of lymph node metastases was investigated using the MT-100-TC mammary carcinoma injected into the hind foot-webs of rats. When the primary tumor was removed by amputation one week after injection, 1/15 animals survived; in contrast, removal of the draining popliteal lymph node in addition to the primary lesion, resulted in 8/19 long-term survivors. At this time, occult metastases detectable by bioassay but not by conventional histology, were present in all draining popliteal nodes and in 60 percent of lungs. The fact that some amputees were cured when the popliteal node was removed, indicated the metachronous nature of nodal metastases in this system. Further, recurrence of nodal and lung metastases in those amputees in which the popliteal node was left intact, identified the popliteal node as a 'generalizing' site. By the time popliteal node involvement was evident by conventional histology, micrometastases were present in 'down-stream' nodes, and accordingly, removal of the popliteal node and the primary lesion at this time was not curative.

Entities:  

Mesh:

Year:  1989        PMID: 2611404     DOI: 10.1007/bf01806303

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  4 in total

1.  Experiments on lymph node metastasis by intralymphatic inoculation of rat ascites tumor cells, with special reference to lodgement, passage, and growth of tumor cells in lymph nodes.

Authors:  Y Kurokawa
Journal:  Gan       Date:  1970-10

2.  Establishment of two nonmetastasizing and one metastasizing rat mammary carcinoma cell lines.

Authors:  S K Ghosh; O A Roholt; U Kim
Journal:  In Vitro       Date:  1983-12

3.  The relationship between lymphogenous and hematogenous metastasis in rats bearing the MT-100-TC mammary carcinoma.

Authors:  P M Ward; L Weiss
Journal:  Clin Exp Metastasis       Date:  1989 May-Jun       Impact factor: 5.150

4.  The pattern and timing of lymphatic metastasis of the rat carcinoma LMC.

Authors:  B Dixon; D A Bagnall
Journal:  Clin Exp Metastasis       Date:  1986 Apr-Jun       Impact factor: 5.150

  4 in total
  10 in total

Review 1.  The connectivity of lymphogenous and hematogenous tumor cell dissemination: biological insights and clinical implications.

Authors:  Jonathan P Sleeman; Blake Cady; Klaus Pantel
Journal:  Clin Exp Metastasis       Date:  2012-06-06       Impact factor: 5.150

2.  Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.

Authors:  Markwin G Statius Muller; Paul A M van Leeuwen; Paul J van Diest; Rik Pijpers; Robert J Nijveldt; Ronald J C L M Vuylsteke; Sybren Meijer
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

Review 3.  Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?

Authors:  Sunny Y Wong; Richard O Hynes
Journal:  Cell Cycle       Date:  2006-04-17       Impact factor: 4.534

Review 4.  Adhesion mechanisms in lymphatic metastasis.

Authors:  P Brodt
Journal:  Cancer Metastasis Rev       Date:  1991-05       Impact factor: 9.264

Review 5.  Targeting tumor cell motility to prevent metastasis.

Authors:  Trenis D Palmer; William J Ashby; John D Lewis; Andries Zijlstra
Journal:  Adv Drug Deliv Rev       Date:  2011-06-02       Impact factor: 15.470

Review 6.  Lymphatic metastasis in breast cancer: importance and new insights into cellular and molecular mechanisms.

Authors:  Suzanne Eccles; Lenaic Paon; Jonathan Sleeman
Journal:  Clin Exp Metastasis       Date:  2007-11-06       Impact factor: 5.150

Review 7.  The Contribution of Angiogenesis to the Process of Metastasis.

Authors:  Diane R Bielenberg; Bruce R Zetter
Journal:  Cancer J       Date:  2015 Jul-Aug       Impact factor: 3.360

8.  Impact of sentinel lymphadenectomy on survival in a murine model of melanoma.

Authors:  Robert B Rebhun; Alexander J F Lazar; Isaiah J Fidler; Jeffrey E Gershenwald
Journal:  Clin Exp Metastasis       Date:  2008-02-09       Impact factor: 5.150

Review 9.  Myeloid derived suppressor cells and the release of micro-metastases from dormancy.

Authors:  Saraswoti Khadge; Kathryn Cole; James E Talmadge
Journal:  Clin Exp Metastasis       Date:  2021-05-20       Impact factor: 4.510

10.  Relationship of CD44+CD24-/low breast cancer stem cells and axillary lymph node metastasis.

Authors:  Wei Wei; Hui Hu; Haosheng Tan; Louis W C Chow; Adrian Y S Yip; Wings T Y Loo
Journal:  J Transl Med       Date:  2012-09-19       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.